index picture
 
 
 
 
 
 

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Your online source for Smart Nutrition Supplements
Serving a growing Nootropic community
 
View Shopping Cart
view cart

Information
Digital-Scale

Muscle Powders

 

subscribe

 

Nootropic-Drink
Nootropic-Drink


 

        A controlled clinical trial on the effect of piracetam in epileptic children.
Author(s): Kunneke PS, Malan GM.
Source: Br J Clin Pract. 1979 September; 33(9): 266-71. No Abstract Available.
> click here to read more <

        A controlled trial of piracetam in intellectually impaired patients with Parkinson's disease.
Author(s): Sano M, Stern Y, Marder K, Mayeux R.
Source: Movement Disorders : Official Journal of the Movement Disorder Society. 1990; 5(3): 230-4.
> click here to read more <

        A double blind investigation of piracetam (Nootropil) vs. placebo in geriatric memory.
Author(s): Abuzzahab FS Sr, Merwin GE, Zimmermann RL, Sherman MC.
Source: Pharmakopsychiatr Neuropsychopharmakol. 1977 March; 10(2): 49-56.
> click here to read more <

       A double blind trial of piracetam (UCB 6215) and placebo in cases of post-ECT cognitive deficiency.
Author(s): Bagadia VN, Gada MT, Mundra VK, Simon S, Doshi JM, Pradhan PV, Shah LP, Sheth UK.
Source: Journal of Postgraduate Medicine. 1980 April; 26(2): 116-20.
> click here to read more <

A double-blind study on the effects of piracetam upon perceptual and psychomotor performance at varied heart rates in patients treated with artificial pacemakers.
Author(s): Lagergren K, Levander S.
Source: Psychopharmacologia. 1974; 39(1): 97-104.
> click here to read more <

       A high-performance liquid-chromatographic microanalytical procedure for the rapid estimation of piracetam in plasma or cerebrospinal fluid.
Author(s): Doheny MH, O'Connell MT, Patsalos PN.
Source: The Journal of Pharmacy and Pharmacology. 1996 May; 48(5): 514-6.
> click here to read more <

        A pilot study of piracetam in cuprophan hemodialysis.
Author(s): Grekas D, Alivanis P, Karamouzis M, Pyrpasopoulos M, Tourkantonis A.
Source: Artificial Organs. 1989 October; 13(5): 422-6.
> click here to read more <

A trial of piracetam in two subgroups of students with dyslexia enrolled in summer tutoring.
Author(s): Ackerman PT, Dykman RA, Holloway C, Paal NP, Gocio MY.
Source: Journal of Learning Disabilities. 1991 November; 24(9): 542-9.
> click here to read more <

        Action of piracetam in childbirth.
Author(s): Elera JH, Sanchez PM, Garay JP.
Source: J Int Med Res. 1980; 8(3): 232-41. No Abstract Available.
> click here to read more <

       Acute and chronic effects of piracetam administration on the bereitschaftspotential in normal children.
Author(s): Chiarenza GA, Grioni AG, Ragaini C, Guareschi-Cazzullo A.
Source: Electroencephalogr Clin Neurophysiol Suppl. 1987; 40: 514-20. No Abstract Available.
> click here to read more <

       Antimyoclonic action of piracetam.
Author(s): Obeso JA, Artieda J, Luquin MR, Vaamonde J, Martinez Lage JM.
Source: Clinical Neuropharmacology. 1986; 9(1): 58-64.
> click here to read more <

        Availability and plasma clearance of piracetam in man.
Author(s): Gobert JG, Baltes EL.
Source: Farmaco [prat]. 1977 February; 32(2): 83-91. No Abstract Available.
> click here to read more <

        Behavioral effects of piracetam in rats with isolation syndrome.
Author(s): Petkov VV, Rousseva S, Dimov S.
Source: Acta Physiol Pharmacol Bulg. 1984; 10(3): 3-9.
> click here to read more <

Clinical efficacy of piracetam in cognitive impairment: a meta-analysis.
Author(s): Waegemans T, Wilsher CR, Danniau A, Ferris SH, Kurz A, Winblad B.
Source: Dementia and Geriatric Cognitive Disorders. 2002; 13(4): 217-24.
> click here to read more <

Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs.
Author(s): Gualtieri F, Manetti D, Romanelli MN, Ghelardini C.
Source: Current Pharmaceutical Design. 2002; 8(2): 125-38. Review.
> click here to read more <

Does piracetam counteract the ECT-induced memory dysfunctions in depressed patients?
Author(s): Mindus P, Cronholm B, Levander SE.
Source: Acta Psychiatrica Scandinavica. 1975 June; 51(5): 319-26.
> click here to read more <

Dose-effect relationship of idebenone in an experimental cerebral deficit model. Pilot study in healthy young volunteers with piracetam as reference drug.
Author(s): Schaffler K, Hadler D, Stark M.
Source: Arzneimittel-Forschung. 1998 July; 48(7): 720-6.
> click here to read more <

Effect of piracetam on cognitive performance in patients undergoing bypass surgery.
Author(s): Uebelhack R, Vohs K, Zytowski M, Schewe HJ, Koch C, Konertz W.
Source: Pharmacopsychiatry. 2003 May; 36(3): 89-93.
> click here to read more <

Effect of Piracetam on dyslexic's reading ability.
Author(s): Wilsher C, Atkins G, Manfield P.
Source: Journal of Learning Disabilities. 1985 January; 18(1): 19-25.
> click here to read more <

       Effect of piracetam on the single word and prose reading of dyslexic children.
Author(s): Helfgott E, Rudel RG, Krieger J.
Source: Psychopharmacology Bulletin. 1984 Fall; 20(4): 688-90.
> click here to read more <

Effect of piracetam on verbal memory of dyslexic boys.
Author(s): Rudel RG, Helfgott E.
Source: J Am Acad Child Psychiatry. 1984 November; 23(6): 695-9. No Abstract Available.
> click here to read more <

       Effects of different drugs on the higher nervous activity in man. Piracetam.
Author(s): Hrbek J, Macakova J, Komenda S, Dostalova K, Medek A, Navratil J.
Source: Acta Univ Palacki Olomuc Fac Med. 1980; 94: 183-98. No Abstract Available.
> click here to read more <

       Effects of piracetam in children with learning disorders. 
Author(s): Simeon J, Waters B, Resnick M.
Source: Psychopharmacology Bulletin. 1980 July; 16(3): 65-6.
> click here to read more <


Effects of piracetam on developmental dyslexia.
Author(s): Wilsher CR.
Source: International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 1986 May; 4(1): 29-39. Review.
> click here to read more <

Effects of Piracetam on dyslexic's verbal conceptualizing ability.
Author(s): Wilsher CR, Milewski J.
Source: Psychopharmacology Bulletin. 1983; 19(1): 3-4.
> click here to read more <

Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain.
Author(s): Muller WE, Koch S, Scheuer K, Rostock A, Bartsch R.
Source: Biochemical Pharmacology. 1997 January 24; 53(2): 135-40.
> click here to read more <

Effects of piracetam on regional cerebral blood flow and mental functions in patients with organic dementia.
Author(s): Gustafson L, Risberg J, Johanson M, Fransson M, Maximilian VA.
Source: Psychopharmacology. 1978 March 1; 56(2): 115-7.
> click here to read more <

Effects of pyrithioxine, centrophenoxine, and piracetam on verbal learning.
Author(s): Hrbek J, Macakova J, Komenda S, Dostalova K, Medek A, Navratil J.
Source: Act Nerv Super (Praha). 1978 December; 20(4): 260-1. No Abstract Available.
> click here to read more <

       Influence of piracetam and etiracetam compared to placebo, on rCBF and parameters of brain metabolism.
Author(s): Van Aken J, Rolly G.
Source: Acta Anaesthesiol Belg. 1980; 31 Suppl: 21-8.
> click here to read more <

Letter: Treatment of migraine with piracetam and clonidine.
Author(s): Coote NP.
Source: South African Medical Journal. Suid-Afrikaanse Tydskrif Vir Geneeskunde. 1975 October 4; 49(42): 1728.
> click here to read more <

        Piracetam and other structurally related nootropics.
Author(s): Gouliaev AH, Senning A.
Source: Brain Research. Brain Research Reviews. 1994 May; 19(2): 180-222. Review.
> click here to read more <


Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients.
Author(s): Kessler J, Thiel A, Karbe H, Heiss WD.
Source: Stroke; a Journal of Cerebral Circulation. 2000 September; 31(9): 2112-6.
> click here to read more <

Piracetam improves visuomotor and cognitive deficits in early Parkinsonism--a pilot study.
Author(s): Oepen G, Eisele K, Thoden U, Birg W.
Source: Pharmacopsychiatry. 1985 November; 18(6): 343-6.
> click here to read more <

Piracetam in acute stroke: a systematic review.
Author(s): Ricci S, Celani MG, Cantisani TA, Righetti E.
Source: Journal of Neurology. 2000 April; 247(4): 263-6.
> click here to read more <  

        Piracetam: physiological disposition and mechanism of action.
Author(s): Tacconi MT, Wurtman RJ.
Source: Adv Neurol. 1986; 43: 675-85.
> click here to read more <

Piracetam-induced improvement of mental performance. A controlled study on normally aging individuals.
Author(s): Mindus P, Cronholm B, Levander SE, Schalling D.
Source: Acta Psychiatrica Scandinavica. 1976 August; 54(2): 150-60.
> click here to read more <

Single doses of piracetam affect 42-channel event-related potential microstate maps in a cognitive paradigm.
Author(s): Michel CM, Lehmann D.
Source: Neuropsychobiology. 1993; 28(4): 212-21.
> click here to read more <  

      Single-dose piracetam effects on global complexity measures of human spontaneous multichannel EEG.
Author(s): Kondakor I, Michel CM, Wackermann J, Koenig T, Tanaka H, Peuvot J, Lehmann D.
Source: International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 1999 October; 34(1): 81-7.
> click here to read more <

The clinical safety of high-dose piracetam--its use in the treatment of acute stroke.
Author(s): De Reuck J, Van Vleymen B.
Source: Pharmacopsychiatry. 1999 March; 32 Suppl 1: 33-7.
> click here to read more <

The clinical use of piracetam, a new nootropic drug. The treatment of symptoms of senile involution.
Author(s): Stegink AJ.
Source: Arzneimittel-Forschung. 1972 June; 22(6): 975-7.
> click here to read more <


The effectiveness of piracetam in vertigo.
Author(s): Oosterveld WJ.
Source: Pharmacopsychiatry. 1999 March; 32 Suppl 1: 54-60. Review.
> click here to read more <

The use of piracetam in vertigo.
Author(s): Fernandes CM, Samuel J.
Source: South African Medical Journal. Suid-Afrikaanse Tydskrif Vir Geneeskunde. 1985 November 23; 68(11): 806-8.
> click here to read more <

Study of nootropic drugs for anti-anxiety action. Author(s): Petkov VD, Getova D, Mosharrof AH.
Source: Acta Physiol Pharmacol Bulg. 1987; 13(4): 25-30.
> click here to read more <

       DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer. Author(s): Ghelardini C, Galeotti N, Gualtieri F, Romanelli MN, Bucherelli C, Baldi E, Bartolini A.
Source: Naunyn-Schmiedeberg's Archives of Pharmacology. 2002 June; 365(6): 419-26. Epub 2002 May 15.
> click here to read more <

Early sensory deprivation treated with Piracetam (UCB-Dipha 6215) in young rats. Author(s): Myslivecek J, Hassmannova J.
Source: Act Nerv Super (Praha). 1973 May; 15(2): 151-3. No Abstract Available.
> click here to read more <

       Effect of piracetam on learning and brain potentials in rats with early sensory deprivation. Author(s): Myslivecek J, Hassmannova J.
Source: Agressologie. 1978; 19(C): 171-7. No Abstract Available.
> click here to read more <


Effect of piracetam, a nootropic agent, on discrimination learning deficits induced by parental undernutrition and environmental impoverishment in young rats. Author(s):  Jaiswal AK, Upadhyay SN, Bhattacharya SK.
Source: Indian J Exp Biol. 1989 March; 27(3): 269-73.
> click here to read more <

Effect of some drugs, experimental stress and estrus on unstable and fixed conditioned alimentary motor reflexes in cats. Part IV. Author(s): Medek A.
Source: Acta Univ Palacki Olomuc Fac Med. 1985; 112: 121-31. No Abstract Available.
> click here to read more <

Proceedings: An electrophysiological analysis of action of piracetam in rats. Author(s): Myslivecek J, Hassmannova J.     
Source: Act Nerv Super (Praha). 1974; 16(4): 242-4. No Abstract Available.
> click here to read more <

« Back

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player


Delivery Options

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

 


Special Offer
1
Nootropic Drugs

  3

       Try our capped products!



Wholesale Capsules
Wholesale Capsules Advertisment